The largest database of trusted experimental protocols
> Procedures > Health Care Activity > Risk Management

Risk Management

Risk Management: The process of identifying, assessing, and mitigating potential risks in order to minimize their impact on an organization or project.
This includes strategies for anticipating, preveneting, and responding to a variety of risks, such as financial, operational, and regulatory threats.
Effective risk management is crucial for optimizing research protocols, mitigating potential pitfalls, and ensuring the success of scientific endeavors.
Utilizing AI-driven tools like PubCompar.ai can help researchers quickly identify the best protocols from literature, preprints, and patents, and select the optimal solutions for their projects.

Most cited protocols related to «Risk Management»

This category includes a variety of frameworks that involve rating of evidence. Examples include GRADE3 (Guyatt et al., 2011), WHO‐IARC (IARC, 2006), WCRF/AICR (2007), OSHA (2016) and guidance used to produce NTP Monographs (NTP, 2015; OHAT, 2015). Guidance to assess and integrate evidence is based on several factors, often derived from the Bradford‐Hill considerations. However, ‘Rating’ builds on the approaches of the category ‘Causal criteria’ in that more guidance is provided for appraising and integrating evidence.
These approaches usually relate to the second step of the weight of evidence process, including the appraisal of individual studies and rating confidence in the individual lines of evidence (e.g. ‘high confidence,’ ‘sufficient evidence’). Some of them also provide tools based on a matrix for integrating lines of evidence to reach hazard identification conclusions (WHO‐IARC, OHAT, OSHA (2016)). None of these approaches use formal probabilistic techniques, but it is possible to combine application of the structured framework guidance with a more quantitative presentation of conclusions.
Some of these approaches (e.g. GRADE) are designed to be flexible for use in a variety of disciplines and able to be applied under different time and resource constraints in situations corresponding to different levels of urgency (Thayer and Schünemann, 2016).
In EFSA, the scheme presented in the ‘Guidance on a harmonised framework for pest risk assessment and the identification and evaluation of pest risk management options’ (EFSA, 2010a) belongs to this category.
Full text: Click here
Publication 2017
Health Risk Assessment Plague Risk Management
The Safety Attitudes Questionnaire (SAQ) is a refinement of the Intensive Care Unit Management Attitudes Questionnaire, [14 (link),15 ] which was derived from a questionnaire widely used in commercial aviation, the Flight Management Attitudes Questionnaire (FMAQ). [16 ,17 ] The FMAQ was created after researchers found that most airline accidents were due to breakdowns in interpersonal aspects of crew performance such as teamwork, speaking up, leadership, communication, and collaborative decision making. The FMAQ measures crew member attitudes about these topics.
Because 25% of the FMAQ items demonstrated utility in medical settings in terms of the subject covered and factor loadings, they were retained on the SAQ, The new SAQ items were generated by discussions with healthcare providers and subject matter experts. In addition, we relied upon two conceptual models to decide which items to include: Vincent's framework for analyzing risk and safety [8 (link)] and Donabedian's conceptual model for assessing quality [18 (link)] This generated a pool of over 100 new items covering four themes: safety climate, teamwork climate, stress recognition, and organizational climate. Items were evaluated through pilot testing and exploratory factor analyses. This phase of survey development consistently yielded 6 factor-analytically derived attitudinal domains containing 40 items from the survey (two, three, four, and five factor structures were less robust). Three of the targeted themes, safety climate, teamwork climate, and stress recognition, emerged as factors. In particular, safety climate and stress recognition are conceptually quite similar to their counterparts in aviation. [19 ] The fourth targeted theme, organizational climate, consistently emerged as three distinct but related factors, perceptions of management, working conditions, and job satisfaction. Organizational climate plays a decisive role in setting the preconditions for success or failure in managing risks [3 ,4 (link),20 (link)] , and we therefore retained these three factors as part of safety attitude assessment. An additional 20 items were retained because they were deemed interesting and valuable to the unit managers and senior hospital leadership to whom we reported the results of our pilot studies.
The SAQ has been adapted for use in intensive care units (ICU) [15 ,21 ] , operating rooms (OR), general inpatient settings (medical ward, surgical ward, etc.), and ambulatory clinics. For each version of the SAQ, item content is the same, with minor modifications to reflect the clinical area. For example, "In this ICU, it is difficult to discuss mistakes," vs. "In the ORs here, it is difficult to discuss mistakes." The SAQ elicits caregiver attitudes through the 6 factor analytically derived climate scales: teamwork climate; safety climate; job satisfaction; perceptions of management; working conditions; and stress recognition (Figure 1).
The SAQ is a single page (double sided) questionnaire with 60 items and demographics information (age, sex, experience, and nationality). The questionnaire takes approximately 10 to 15 minutes to complete. Each of the 60 items is answered using a five-point Likert scale (Disagree Strongly, Disagree Slightly, Neutral, Agree Slightly, Agree Strongly). Some items are negatively worded. There is also an open-ended section for comments: "What are your top three recommendations for improving patient safety in this clinical area?" Each version of the SAQ in the current study includes a "Collaboration and Communication" section, where respondents are asked to indicate the quality of collaboration and communication they have experienced with each of the types of providers in their clinical area (e.g., Staff Surgeons, Surgical Residents, Staff Anesthesiologists, OR Nurses, etc.) using a five-point Likert scale (Very Low, Low, Adequate, High, Very High).
Full text: Click here
Publication 2006
Accidents Anesthesiologist Catabolism Climate Health Personnel Inpatient Job Satisfaction Nurses Operative Surgical Procedures Patient Safety Risk Management Safety Surgeons

It should be noted that the text in green italics throughout this Guidance aims to provide practical guidance to the assessors to conduct the commodity risk assessment.The Panel performs its commodity risk assessment following the relevant guiding principles and steps presented in the EFSA guidance on quantitative pest risk assessment (EFSA PLH Panel, 2018), in the guidance on evaluation of the effectiveness of risk‐reducing options (EFSA PLH Panel, 2012) and in the International Standard for Phytosanitary Measures No 11 and No 21 (FAO, 2004, 2013a). It should be noted that the Panel's conclusions are formulated to respect its remit and particularly with regard to the principle of separation between risk assessment and risk management (EFSA founding regulation (EU) No. 178/2002).
The data and supporting information provided in the dossier submitted by the applicant form the basis of the commodity risk assessment. In evaluating the dossier provided, EFSA PLH Panel assumes that the applicant followed the instructions contained in the Technical Report (EFSA, 2018).
Guidance is provided on the methodology to be used in the commodity risk assessment and concerns the evaluation of commodity data, identification of pests potentially associated with the commodity and evaluation of the risk mitigation measures.
Examples of databases that could be used for checking the completeness of the information provided are listed below:

EPPO Global Database (https://gd.eppo.int/)

CABI Plant Protection Compendium (https://www.cabi.org/cpc/)

The Plant List (http://www.theplantlist.org/)

Index Fungorum (http://www.indexfungorum.org/)

MycoBank (http://www.mycobank.org/)

NEMAPLEX (http://plpnemweb.ucdavis.edu/)

Fauna Europaea (https://fauna-eu.org/)

EUROPHYT

USDA Agricultural Research Services (https://nt.ars-grin.gov/)

bibliographical databases

statistical databases

When performing a commodity risk assessment, the databases used to check the completeness of the information provided should be explicitly mentioned.At several points in the risk assessment process, additional information may be required. Figure 1 gives an overview of the points in the assessment process when this may be the case. This could include requests for clarifications or additional documentation from the applicant.
Full text: Click here
Publication 2019
Health Risk Assessment Plague Plants Process Assessment, Health Care Risk Management
The hospitalized patients clinical database is an ongoing multicenter registry in Belgium that collects information on hospital admission related to COVID-19 infection. The data are regularly updated as more information from the hospitals are sent in. The individual patients’ data are collected through 2 online questionnaires: one with data on admission and one with data on discharge. Data are reported for all hospitalized patients with a confirmed COVID-19 infection. The reporting is strongly recommended by the Belgian Risk Management Group, therefore the reporting coverage is high (>70% of all hospitalized COVID-19 cases) [3 ].
At the time of writing this manuscript, there is information about 14,618 patients, hospitalized between 1 March 2020 and 12 June 2020, including age and gender. Table A1 (Appendix B) summarizes the age and living status (living in nursing home or not) of the patients. Age is categorized into 4 age groups: the young population (0–20 years), the working age population (20–60 years), the senior population (60–80 years) and the elderly (80+ years). It shows that a large proportion of the hospitalized 60+ patients live in a nursing home facility (about 12% for patients aged 60–79 and 35% for patients aged 80+). The survey contains information on 1831 patients hospitalized during the initial phase of the outbreak (between 1 March and 20 March); 4998 patients in the increasing phase of the outbreak (between 21 March and 31 March); 5094 in the descending phase (between 1 April and 18 April); and 2695 individuals at the end of the first wave of the COVID-19 epidemic (between 19 April and 12 June). The time trend in the number of hospitalizations is presented in Figure A2 (Appendix B). The time trend in the survey matches well with the time trend of the outbreak in the whole population, though with some under-reporting in April and May.
The time variables (time of symptom onset, hospitalisation, diagnosis, and recovery or death) were checked for consistency. Observations identified as inconsistent were excluded for analyses. Details of the inclusion and exclusion criteria are provided in Appendix A. Some descriptive analyses of the event times are provided in Appendix C.
Full text: Click here
Publication 2020
Age Groups COVID 19 Diagnosis Epidemics Gender Patient Discharge Patients Population at Risk Risk Management

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Adrenal Cortex Hormones Adult Contraceptive Methods Creatinine Dialysis Diphosphonates Ethics Committees, Research Heterosexuals Kidney Failure, Acute Malignant Neoplasms Multiple Myeloma Patients Radiotherapy Rehydration Risk Management Serum Urine Woman

Most recents protocols related to «Risk Management»

The study was performed in the region Eindhoven, south-eastern part of the Netherlands, in 145 general practices affiliated to the primary care group PoZoB. The care group covers rural, suburban and urban practices similar to other parts of the Netherlands and therefore can be considered as representative. Between 2010 and 2013, 137 practices (406,119 registered patients) followed a stepwise implementation for integrated care and another 8 practices started implementation between 2013 and 2015. Eligibility for participation in integrated CVRM care was based on in- and exclusion criteria given in Table 1. Details of the stepwise implementation have been described elsewhere [16 (link)].

Criteria for participation in the CVRM program a

Inclusion criteria for patients eligible for primary prevention
● A 10 year cardiovascular mortality risk > 5%, based on the SCORE table from the 2006 CVRM guidelines of the Dutch Society of General Practice [6 (link)]
● Prescription of blood pressure lowering or lipid modifying drugs in men aged ≥ 55 years and women aged ≥ 60 years
● Systolic blood pressure > 180 mm Hg and/or total cholesterol > 8 mmol/l ever measured, independent of the 10 year mortality risk
● The patient is primarily treated in primary care and aged 18 years or above
Inclusion criteria for patients eligible for secondary prevention:
● Documented previous ischemic or atherosclerotic heart disease (myocardial infarction and angina pectoris), heart failure, atrial fibrillation, aneurysm of the abdominal aorta, peripheral arterial disease, transient ischemic attack, ischemic or hemorrhagic stroke, chronic kidney disease
● The patient is primarily treated in primary care and aged 18 years or above
Exclusion criteria for both groups were:
● Primarily treated for cardiovascular disease risk by a specialist in a hospital or at an outpatient clinic
● Diabetes mellitus (patients receive cardiovascular risk management in a diabetes care program)
● Patients younger than 18 years

aCVRM program: cardiovascular risk management program

Full text: Click here
Publication 2023
Angina Pectoris Aortic Aneurysm, Abdominal Atrial Fibrillation Cardiovascular Diseases Cardiovascular System Cholesterol Chronic Kidney Diseases Congestive Heart Failure Coronary Arteriosclerosis Diabetes Mellitus Eligibility Determination Hemorrhagic Stroke Lipids Myocardial Infarction Patients Peripheral Vascular Diseases Pharmaceutical Preparations Primary Health Care Primary Prevention Risk Management Secondary Prevention Specialists Systolic Pressure Transient Ischemic Attack Woman Youth
ASSIP is provided by licensed mental health professionals following routine clinic protocols for in-person, over the phone, or video conference crises. Therapists are accustomed to treating high-risk individuals. Study staff followed an IRB-approved risk management protocol and received supervision from investigators on all clinical interviews.
Given the nature of this study, suicide attempts and psychiatric hospitalisations are expected to occur and to be non-study related in most cases. As such, these serious adverse events (SAEs) are reported in summary reports to the Data and Safety Monitoring Board (DSMB), with annual reports to the National Institute of Mental Health (NIMH) and IRB. Suicide deaths are reported to the DSMB within 48 hours of discovery, with investigators’ judgments as to whether a relationship to the study can be ruled out. The DSMB members either concur or request additional investigation as an SAE. Suicide deaths are reported to the IRB and NIMH within 5 business days of discovery with the investigators’ and DSMB’s determination regarding whether a relationship to the study can/cannot be ruled out and any recommendations made by the DSMB.
After reviewing the circumstances and consulting with coinvestigators, a designated unblinded coinvestigator can reclassify an adverse event as an SAE. SAEs deemed unexpected and study related are reported to the IRB and NIMH within 5–7 working days of discovery. If considered related to the study, unanticipated adverse events involving risks to participants or others are reported by the principal investigator and/or DSMB to the IRB, and the IRB promptly informs the NIMH. The DSMB, IRB, and NIMH can recommend corrective actions to be taken by the investigators.
Publication 2023
Clinical Protocols Clinical Trials Data Monitoring Committees Hospitalization Mental Health Risk Management Suicide Attempt Supervision
The Panel performed the pest categorisation for P. ananatis, following guiding principles and steps presented in the EFSA guidance on quantitative pest risk assessment (EFSA PLH Panel et al., 2018 (link)), the EFSA guidance on the use of the weight of evidence approach in scientific assessments (EFSA Scientific Committee, 2017 (link)) and the International Standards for Phytosanitary Measures No. 11 (FAO, 2013 ).
The criteria to be considered when categorising a pest as a potential Union QP is given in Regulation (EU) 2016/2031 Article 3 and Annex I, Section 1 of the Regulation. Table 1 presents the Regulation (EU) 2016/2031 pest categorisation criteria on which the Panel bases its conclusions. In judging whether a criterion is met the Panel uses its best professional judgement (EFSA Scientific Committee et al., 2017 (link)) by integrating a range of evidence from a variety of sources (as presented above in Section 2.1) to reach an informed conclusion as to whether or not a criterion is satisfied.
The Panel's conclusions are formulated respecting its remit and particularly with regard to the principle of separation between risk assessment and risk management (EFSA founding regulation (EU) No 178/2002); therefore, instead of determining whether the pest is likely to have an unacceptable impact, deemed to be a risk management decision, the Panel will present a summary of the observed impacts in the areas where the pest occurs, and make a judgement about potential likely impacts in the EU. Whilst the Panel may quote impacts reported from areas where the pest occurs in monetary terms, the Panel will seek to express potential EU impacts in terms of yield and quality losses and not in monetary terms, in agreement with the EFSA guidance on quantitative pest risk assessment (EFSA PLH Panel et al., 2018 (link)). Article 3 (d) of Regulation (EU) 2016/2031 refers to unacceptable social impact as a criterion for QP status. Assessing social impact is outside the remit of the Panel.
Full text: Click here
Publication 2023
Health Risk Assessment Plague Risk Management

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
COVID 19 Police Officer Risk Management Safety Secure resin cement Special Education Student Supervision

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Risk Management Safety Secure resin cement Student

Top products related to «Risk Management»

Sourced in United States, Germany, China, Canada, France, United Kingdom, Switzerland
The Bioanalyzer 2100 system is a lab equipment product from Agilent Technologies. It is designed to perform automated electrophoretic analysis of DNA, RNA, and proteins. The system provides quantitative and qualitative data on the size, concentration, and integrity of these biomolecules.
Sourced in United States, Germany, China, Japan, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Belgium, Denmark, Netherlands, India, Ireland, Lithuania, Singapore, Sweden, Norway, Austria, Brazil, Argentina, Hungary, Sao Tome and Principe, New Zealand, Hong Kong, Cameroon, Philippines
TRIzol is a monophasic solution of phenol and guanidine isothiocyanate that is used for the isolation of total RNA from various biological samples. It is a reagent designed to facilitate the disruption of cells and the subsequent isolation of RNA.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.
The X-Ten sequencing system is a high-throughput DNA sequencing instrument designed for large-scale genomic studies. It utilizes sequencing-by-synthesis technology to generate extensive genomic data. The X-Ten system is capable of producing vast amounts of sequencing data per run, enabling researchers to conduct comprehensive genome analyses efficiently.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Germany, United Kingdom, Japan, Switzerland, Canada, Australia, Netherlands, Morocco
LabVIEW is a software development environment for creating and deploying measurement and control systems. It utilizes a graphical programming language to design, test, and deploy virtual instruments on a variety of hardware platforms.
Sourced in United States, Denmark, Austria, United Kingdom, Japan
Stata version 15 is a data analysis and statistical software package. It provides a range of tools for data management, statistical analysis, and visualization. Stata version 15 supports a variety of data types and offers a comprehensive set of statistical procedures.
Sourced in United States, United Kingdom, Austria, Denmark
Stata 15 is a comprehensive, integrated statistical software package that provides a wide range of tools for data analysis, management, and visualization. It is designed to facilitate efficient and effective statistical analysis, catering to the needs of researchers, analysts, and professionals across various fields.
Sourced in United States
The Pierce Magnetic ChIP Kit is a tool designed for chromatin immunoprecipitation (ChIP) experiments. It utilizes magnetic beads coated with protein A or protein G to capture antibody-bound chromatin fragments, enabling efficient isolation and purification of DNA sequences associated with specific proteins of interest.
Sourced in United States, Germany, Australia
The DR 2800 spectrophotometer is a laboratory instrument designed for accurate and reliable absorbance measurements. It operates in the visible and near-infrared wavelength ranges, allowing users to perform a variety of analytical tests. The device features a compact and durable design, making it suitable for use in various laboratory settings.

More about "Risk Management"

Risk management is a critical component of scientific research and project management.
It involves the systematic identification, assessment, and mitigation of potential risks that could impact the success of a research project or scientific endeavor.
Effective risk management strategies utilize a variety of tools and techniques, such as the Bioanalyzer 2100 system, TRIzol reagents, Stata statistical software (versions 14 and 15), X-Ten DNA sequencing, SAS analytics (version 9.4), LabVIEW for instrumentation control, and the Pierce Magnetic ChIP Kit for chromatin immunoprecipitation.
These tools and techniques can help researchers anticipate, prevent, and respond to a range of risks, including financial, operational, regulatory, and technical threats.
By identifying and addressing potential pitfalls early in the research process, researchers can optimize their protocols, minimize the impact of unforeseen challenges, and increase the likelihood of successful outcomes.
The use of AI-driven tools, like PubCompare.ai, can further enhance risk management by rapidly identifying the best protocols from the literature, preprints, and patents.
This allows researchers to quickly assess and select the optimal solutions for their projects, reducing the risk of costly missteps or delays.
Effective risk management is crucial for the success of scientific endeavors, as it helps researchers navigate the complex and dynamic landscape of research and development.
By utilizing a range of tools and techniques, researchers can mitigate risks, optimize their research protocols, and ensure the success of their scientific projects.
Whether you're working with the DR 2800 spectrophotometer or any other research equipment, incorporating robust risk management strategies is essential for advancing scientific knowledge and achieving your research goals.